On the inevitability scale, death and taxes are at the top. Aging is close behind.

It’s unlikely that scientists will ever find a way to avoid death. And taxes are completely out of their hands. But aging, recent research suggests, is a problem that science just might be able to fix.

As biological scientists see it, aging isn’t just accumulating more candles on your birthday cake. It’s the gradual deterioration of proteins and cells over time until they no longer function and can’t replenish themselves. In humans, aging manifests itself outwardly as gray hair, wrinkles and frail, stooped bodies. Inside, the breakdown can lead to diabetes, heart disease, cancer, Alzheimer’s disease and a host of other problems.
Scientists have long passionately debated why cells don’t stay vigorous forever. Research in mice, fruit flies, worms and other lab organisms has turned up many potential causes of aging. Some experts blame aging on the corrosive capability of chemically reactive oxygen molecules or “oxidants” churned out by mitochondria inside cells. DNA damage, including the shortening of chromosome endcaps (called telomeres) is also a prime suspect. Chronic, low-grade inflammation, which tends to get worse the older people get, wreaks so much havoc on tissues that some researchers believe it is aging’s prime cause, referring to aging as “inflammaging.” All these things and more have been proposed to be at the root of aging.
Some researchers, like UCLA’s Steve Horvath, view aging as a biological program written on our DNA. He has seen evidence of a biological clock that marks milestones along life’s path. Some people reach those milestones more quickly than others, making them older biologically than the calendar suggests. Others take a more leisurely stroll, becoming biological youngsters compared with their chronological ages.

Many others, including Richard Miller, a geroscientist at the University of Michigan, deny that aging is programmed. Granted, a biological clock may measure the days of our lives, but it’s not a ticking time bomb set to go off on a particular date. After all, humans aren’t like salmon, which spawn, age and die on a schedule.

Instead, aging is a “by-product of running the engine of life,” says biodemographer Jay Olshansky of the University of Illinois at Chicago. Eventually bodies just wear out. That breakdown may be predictable, but it’s not premeditated.
Despite all the disputes about what aging is or isn’t, scientists have reached one radical consensus: You can do something about it. Aging can be slowed (maybe even stopped or reversed). But exactly how to accomplish such a counterattack is itself hotly debated. Biotechnology and drug companies are developing several different potential remedies. Academic scientists are investigating many antiaging strategies in animal experiments. (Most of the research is still being done on mice and other organisms because human tests will take decades to complete.)
Even researchers who think they have finally come up with real antiaging elixirs say they don’t have the recipe for immortality, though. Life span and health span, new research suggests, are two entirely separate things. Most researchers who work on aging aren’t bothered by that revelation. Their goal is not necessarily extending life span, but prolonging health span — the length of time people live without frailty and major diseases.

Aging as disease
Many health problems are so commonly associated with aging that some researchers take the highly controversial stance that aging itself is a disease, says Saul Villeda of the University of California, San Francisco.

If aging is a disease, in Villeda’s lab it’s almost a contagious one: He can artificially spread aging from old lab mice to young ones. One mode of aging transmission is to give genetically identical mice transfusions of young or old blood. In another approach, researchers sew together pairs of mice so that their blood vessels will join up and link their circulatory systems.

This artificial joining of two separate animals, known as parabiosis, was a staple of physiology experiments for over a century before Irina Conboy got the idea to pair an old mouse with a young one. Conboy, a stem cell researcher at the University of California, Berkeley, made headlines with her experiments.
Those headlines focused on the good news: Young blood rejuvenated old mice. In further studies by other researchers, infusions of young blood made broken bones in old mice heal better (SN Online: 5/19/15), gave their muscles extra spring and improved their memories (SN: 5/31/14, p. 8). Apparently some substances in the blood triggered the rejuvenation. Some candidates for those rejuvenation factors have been identified, although none are universally agreed on.

But news accounts mostly ignored the flip side of the experiment: Being tethered to an old mouse made young mice age faster. One substance in the blood of old mice, a protein called Beta‑2‑microglobulin, or B2M, seemed to prematurely age the young ones, Villeda and colleagues reported last year in Nature Medicine (SN: 8/8/15, p. 10). Parabiosis experiments don’t last very long, so no one knows whether youth or decrepitude will win in the end — or if the two mice would have settled into middle age together.

UCLA’s Horvath has evidence that the mice may never totally sync. He monitors aging by examining molecular tags called methyl groups, which attach to various locations on DNA in a process called methylation. Methylation is an epigenetic modification of DNA. Such modifications work something like flagging passages in a book with sticky notes. Attaching a tag doesn’t change the information in the book — it just draws attention to some passages and signals that others should be ignored.

Horvath measures DNA methylation changes at 353 different spots in the human genetic instruction book, or genome. As people age, 193 locations accumulate tags, like playbills plastered on urban buildings. At 160 others, methylation is gradually stripped away with age. Knowing how much methylation is normally found at each spot at a given chronological age allows Horvath to calculate biological age.
Some people age at different rates than others, he discovered. For instance, semi-supercentenarians — people who live to be 105 to 109 — are about 8.6 years younger epigenetically than their chronological age. Their children are slow to age, too, though not as slow as their parents. Epigenetic clocks indicate that the offspring are about five years younger biologically than other people of the same chronological age.

People often joke about certain abilities, such as eyesight, memory or hearing being “the first to go.” Some of Horvath’s work suggests that the notion isn’t entirely far-fetched. He calculated the epigenetic age of specific organs and discovered that body parts can age at different rates. The cerebellum, the part of the brain that sits at the top of the brain stem and helps coordinate movement, speech and other activities, ages the slowest of the brain regions that Horvath analyzed. While there are natural differences in organ aging, some conditions, such as HIV infection and obesity, can prematurely age certain organs, Horvath and colleagues have found.

These experiments demonstrate that aging and its effects are malleable. “Aging is really plastic — it’s not set in stone,” says Conboy. Consequently, she and other researchers agree, something can be done to slow aging, or perhaps turn it around entirely. But exactly what can be done is vigorously disputed.

Interpret with caution
Most scientists working on aging urge caution in extrapolating promising results in animal studies to humans. For instance, one of the most promising early candidates for a rejuvenation factor from young blood was a protein called GDF11. Reports in 2013 and 2014 concluded that GDF11 levels in blood decline with age; restoring the protein in old animals could reverse some heart problems, improve muscle strength and spur nerve cell growth in the brain. 
Since those reports, other researchers have disputed the protein’s revitalizing powers. In a recent study, researchers measured GDF11 levels in 140 people aged 21 to 93. Levels of the protein didn’t decline with age, Mayo Clinic researchers reported in the June 14 Cell Metabolism. Previous researchers may have gotten GDF11 mixed up with a similar protein called myostatin, which does dip as people get older. Not only does GDF11 not decline with age, having too much of it could be bad, the Mayo team found. People with higher blood levels of the protein were more likely to be frail, have diabetes and heart problems, and have a more difficult time recovering from surgery than people with lower levels of the protein.

Beyond the blood experiments, scientists have examined various ideas about what goes wrong in aging and have devised strategies to counteract it. For instance, some evidence suggests that stem cells run out of steam as they get older. Restoring old stem cells to youthful vigor may enable them to repair or replace damaged tissues and turn back the biological clock. Keeping stem cells youthful may involve sheltering them from inflammation or things that could damage their DNA.

One way to keep stem cells and other cells working is to avoid the loss of telomeres capping the ends of chromosomes. As cells divide, their telomeres grow shorter until they are so short that chromosomes can no longer safely replicate. That may be a signal for the cell to shut down or die. So some researchers think that lengthening telomeres could give cells the protection needed to survive longer.

One biotechnology company executive flew from the United States to Colombia to try out her company’s gene therapy for lengthening telomeres. That decision bypassed U.S. government and other safety measures designed to protect human study participants. And no one knows whether it will work or doom her to cancer, which often relies on long telomeres to keep growing.

Other researchers are exploring more measured approaches to antiaging therapies. One study in dogs is testing rapamycin, the first drug shown to lengthen mouse life spans. Rapamycin is an immune suppressant that also has anticancer effects. The rationale for using it came from research on caloric restriction, the world-champion method for making animals live longer. Animals on calorie-restricted diets typically eat at least 25 percent fewer calories than normal. Such low-cal treatment has increased life spans in mice, dogs, fruit flies, yeast, worms and other lab organisms. Results from primate studies have been mixed (SN: 8/1/09, p. 9; SN: 10/6/12, p. 8). Some people have put themselves on caloric-restriction regimes (SN: 10/25/08, p. 17). A handful of studies suggest that those people have better health, but it’s too soon to know whether they will outlive their peers.

Exactly why drastically reducing food intake can extend life isn’t known. But researchers have good evidence that a series of biochemical reactions known as the mTOR pathway is involved. The protein mTOR helps monitor nutrient levels in cells and regulates cell movement, protein production, and cell growth and survival. When starvation sets in, cells turn off mTOR’s activity, which allows a self-cannibalizing process called autophagy to scavenge nutrients by digesting some of the cell’s internal organs. This internal garbage disposal and recycling method also removes old, worn-out mitochondria and proteins that may otherwise keep cells from functioning efficiently. That process and other cellular activities governed by mTOR may be responsible for making cells, and organisms, live longer.
Rapamycin gave mTOR its name — mechanistic target of rapamycin. Giving the drug might do what caloric restriction does without requiring superstrict diets (SN: 6/4/11, p. 22). Matt Kaeberlein, a geroscientist at the University of Washington, and colleagues conducted a safety study of the drug last year in 24 dogs. The study was only 10 weeks long, so the researchers can’t yet draw any conclusions about long-term effects on aging. But the dogs had no major side effects from taking low doses of the drug, a worry because rapamycin impairs immune system function and could make animals (including people) who take it more vulnerable to infection or cancer.

Rapamycin’s drawbacks make it unattractive for human studies. The diabetes drug metformin may instead be the antiaging drug of choice for people, says gerontologist Nir Barzilai. In addition to mTOR, metformin targets an insulin-like growth protein known as IGF-1. That protein has been implicated in a variety of biological processes that promote aging.

Barzilai, of Albert Einstein College of Medicine in New York City, and researchers at more than a dozen centers around the country plan to test metformin for its ability to fight aging in people 65 to 79. Barzilai and colleagues laid out the case for using metformin in the June 14 Cell Metabolism. Metformin is generally safe, with few major side effects. It has been shown to improve a variety of health measures and to impair cancer development in people with type 2 diabetes (SN: 11/30/13, p. 18). Barzilai says the drug may help people who don’t have diabetes also live healthier when they are elderly. If it does, commercials touting metformin might have to add another disclaimer, he jokes. “The commercials will go on: ‘This will make you healthy, but we have to apologize because you might live longer.’ ”

But studies of mice suggest that disclaimer may not be necessary. Research by Miller and others suggests that metformin may not prolong life. They have been dosing mice with various chemicals, including metformin and rapamycin, looking for drugs that will make mice healthier and live longer. In a new study, published online June 16 in Aging Cell, Miller and colleagues fed mice metformin starting when the rodents were 9 months old — middle age for a mouse. Combining metformin and rapamycin didn’t make the mice live much longer than rapamycin alone did in previous trials.

Cellular zombies
Other researchers are hoping to stave off death by getting rid of the undead. Cellular zombies called senescent cells are stressed cells that have entered a type of stasis — they’re not dead, but they’re not functioning either. Stress for cells usually means severe DNA damage that could produce cancer, critically short telomeres or other molecular catastrophes that trigger shutdown mode.
That lockdown is for the greater good, says aging researcher Judith Campisi, who studies senescence at the Buck Institute for Research on Aging in Novato, Calif. “It’s protective,” she says. “You don’t want defective cells to propagate.” (When damaged cells continue to grow they may become cancerous.)

Unfortunately, says Campisi, the senescent cells don’t die. Instead they send out messages to neighboring cells: “Hey, there’s a problem. Be prepared. What happened to me could happen to you.” Such messages are probably intended as public service announcements, but they could trigger mass panic and inflammation. Like zombies putting the bite on the living, senescent cells damage surrounding cells and accelerate aging.

Researchers have worked out methods for hitting the zombie cells with genetic shots to the head, effectively destroying the cells and removing them from the body. Mice from which senescent cells have been removed had increased median life span and improved health, researchers reported in Nature in February (SN: 3/5/16, p. 8).

Campisi and other researchers are working on ways to clear senescent cells from humans, too. But no antiaging treatment makes mice or any other animal live forever. Researchers have yet to increase a mouse’s life span (which rarely goes above two years) to five years, although one mouse fell just short of that mark.

Much research suggests that things that extend life span, such as rapamycin, might not stretch health spans. Mutations that make millimeter-long transparent worms known as Caenorhabditis elegans live longer also extend the proportion of their lives the worms spend being frail, Heidi Tissenbaum of the University of Massachusetts Medical School in Worcester and colleagues reported last year in the Proceedings of the National Academy of Sciences.

But living healthy doesn’t guarantee longevity either, a new study of sea urchins suggests. Red sea urchins (Mesocentrotus franciscanus) live well past 100 years old in the wild, while purple sea urchins (Strongylocentrotus purpuratus) make it to 50. But variegated (also called “green”) sea urchins (Lytechinus variegatus) normally die after four years.
The difference in the species’ life spans might be due to different rates of aging, thought aging researcher Andrea Bodnar at the Bermuda Institute of Ocean Sciences in St. George’s and developmental biologist James Coffman of the MDI Biological Laboratory in Salisbury Cove, Maine. Instead, they found, none of the species seem to age at all . Young and old members of each species are similar in their abilities to reproduce and to regenerate spines and tube feet, the researchers reported online April 20 in Aging Cell . Even though the short-lived variegated urchins have no signs of slowing down, they still die. Why is a mystery, Coffman says.
Ways to be wellderly
A similar paradox is also seen in “wellderly” people that geneticist Ali Torkamani has been studying at the Scripps Research Institute in La Jolla, Calif. About eight years ago, Torkamani started bringing in people over 80 who had made it to an advanced age without any sign of chronic disease. The idea was to study their DNA and learn the secrets of healthy aging.

Despite living healthy, the wellderly didn’t carry genetic variants connected with extremely long lives, Torkamani and colleagues discovered. The wellderly also had no genetic advantage when it comes to cancer, stroke or diabetes. What they did have was a lower risk of getting Alzheimer’s and heart disease. Each of the wellderly seemed to have their own genetic recipe for success, suggesting there are lots of ways to stay healthy into old age. The researchers didn’t rule out that diet and lifestyle also help. “There’s hope for everybody,” Torkamani declares.

But his cloud of optimism may have a tarnished lining. His findings, along with the sea urchin and worm results, suggest that aging and longevity aren’t the same things. If that’s the case, it would mean that stopping aging would not extend human life span by much. The oldest (verified) person to have ever lived was Jeanne Louise Calment, a French woman who died at age 122 in 1997. People might top out at 130 if aging is controlled (and most people still would not make it that long because they just don’t have the necessary makeup). As a species, humans probably can’t go further without changing whatever controls longevity too, some researchers think.

Exactly how long people can live won’t be answered until proven antiaging therapies are developed. If aging and longevity are linked, then treating aging could very well make people live longer, healthier lives. If they are separate phenomena, then people could forgo the cancer, heart disease and other ailments of aging, but they would still have limited life spans. In that case Star Trek’s Mr. Spock might need to revise his usual parting words. When talking to humans, he should wish that they will live long or prosper. We may not get both.

Happy 40th anniversary, Viking 1! Four decades ago — July 20, 1976 — the robotic probe became the first U.S. mission to land on Mars. Its sister spacecraft, Viking 2, touched down 45 days later.

Launched August 20, 1975, Viking 1 spent over 6 years snapping pictures and studying the soil at its landing site, an ancient crater named Chryse Planitia. An experiment to look for Martian microbes turned up nothing definitive, though some researchers continue to argue otherwise.

Viking 1 wasn’t the first to successfully touch down on the Red Planet. That honor goes to the Soviet probe Mars 3, whichgently landed on Mars in 1971, though its only transmission — a partial, garbled image — lasted just 20 seconds.

Today, seven probes actively call Mars home. A European-led orbiter and lander, ExoMars, is on its way, and NASA has two missions lined up: the Insight lander, whose launch was recently delayed to 2018, and the Mars 2020 rover, which will pick up where the Vikings left off and search for Martian life.

Microbes may have played a role in making us, us. A new study shows similar patterns in the evolution of gut bacteria and the primates they live in, suggesting that germs and apes could have helped shaped one another.

For at least 10 million years, bacteria have been handed down from the common ancestor of humans and African apes. As apes split into separate species, so did the microbes inside them, researchers report July 22 in Science. Now, relationships between gut bacterial species mirror the family tree of gorillas, humans, bonobos and chimpanzees.
Germs are a piece of our history, says evolutionary biologist Andrew Moeller who led the study while at both the University of Texas at Austin and the University of California, Berkeley. “Just like genes we’ve inherited from our ancestors,” he says, “we’ve inherited some of our bacteria from our ancestors as well.”

It’s well known that bacteria are key to human health (SN: 04/02/16, p. 23). They play major roles in the immune system and development. But very few researchers have turned to the past, Moeller says, to ask how humans got those handy bacteria in the first place. His team studied three families of bacteria living in the feces of people from Connecticut, as well as in that of wild chimps, bonobos and gorillas. The scientists used DNA evidence to build relationship trees for each bacterial family, then compared each tree with known relationships between humans and close primate relatives.

Two of three bacterial trees matched primate relationships. For those families, closely related bacteria live in closely related primates. For humans, “the closest relatives of our gut bacteria live in chimpanzees,” Moeller says, “just like our closest relatives are chimps.”

Scientists would expect that pattern to match only if apes and bacteria split into new species in unison. The fact that apes and bacteria split at roughly the same time, while bacteria were living inside of ape species, implies that they were influencing each other, and therefore that the evolution of one group could shape the evolution of the other.

Changing bacteria may have “allowed us to evolve,” says microbial geneticist Julia Segre of the National Human Genome Research Institute in Bethesda, Md., who was not involved in the new work. She and conservationist Nick Salafsky of the nonprofit Foundations of Success, also in Bethesda, wrote a perspective on it in the same issue of Science.

A “very intimate relationship with bacteria,” she says, “is part of who we are.” While the researchers agree that humans and bacteria probably shaped each other’s evolution, they caution that it’s too soon to tell if (and how) ancient apes and microbes changed each other.

Those ancient relationships may get harder to study over time. Industrialization and antibiotics have reduced the diversity of bacteria living in and on humans, Moeller says. And while the microbes in this study have stuck around, other groups may have disappeared or changed dramatically.

One caveat, Segre says, is that humans have been exposed to antibiotics and modern life. Wild African apes might still have their ancient gut flora, but people in Connecticut might not (SN: 12/13/14, p. 10). It’s especially important to do studies like this now, she says, “because it’s not going to get better.”

In the future, Moeller says, researchers should look deeper into the past to see if the gut bacteria living in all mammals share one common ancestor. Scientists could also go the other way, he says, to see if more recently divided human populations also have characteristic gut bacteria.

How can aging be delayed? How does the brain age? And what does aging look like in animals, plants or the rest of the natural world? The July 23 issue of Science News tackles these questions and more in a special report called “Aging’s Future.”

On Tuesday, July 26, at 3 p.m. EDT, three Science News reporters will answer questions about aging as part of Reddit’s Ask Me Anything series. Molecular biology reporter Tina Hesman Saey, neuroscience writer Laura Sanders and biology writer Susan Milius will be responding to questions from 3 p.m. to 4 p.m. Eastern at this link.

Read their in-depth features on aging:

A healthy old age may trump immortality: Despite disagreements about what aging is and isn’t, scientists have reached a radical consensus: It can be delayed. By Tina Hesman Saey

The brain’s blueprint for aging is set early in life: The brain’s decline may mirror its beginning, offering clues to aging. By Laura Sanders

Organisms age in myriad ways — and some might not even bother: There is great variety in how animals and plants deteriorate (or don’t) over time. By Susan Milius

Three vaccines offer complete protection against Zika virus in monkeys.

The results are the latest step in the quest to create a Zika vaccine that’s safe and effective for humans (SN Online: 6/28/16).

One vaccine, made with a purified, inactivated form of the virus — designated PIV — helped rhesus monkeys fend off infection from both a Zika strain from Brazil and one circulating in Puerto Rico, study coauthor Nelson Michael and colleagues report August 4 in Science. A second DNA-based vaccine that uses snippets of Zika’s genetic material to rev up the immune system was tested against a Brazilian strain. So was a third type of vaccine that relies on a virus called adenovirus to carry Zika genes into the monkeys’ bodies.
In recent days, the U.S. government and Inovio Pharmaceuticals have both started human safety trials for two other DNA-based candidates. But Michael, a vaccine researcher at the Walter Reed Army Institute of Research in Silver Spring, Md., thinks the PIV vaccine may have the best shot.

“It’s the one that’s probably going to go the distance,” he says.

DNA-based vaccines have never before been licensed for use in humans, he notes. The technique to make a PIV vaccine “goes back to Jonas Salk and polio,” Michael says. Essentially, researchers grow Zika in a lab, kill it and then purify it. “It’s a classic way to make a vaccine,” he says. “And you know what? It works.”

Human testing of the PIV vaccine will start in October. Still, Michael says evaluating many vaccine candidates is important. Any number of factors, from a bad reaction to a bankrupt manufacturer, can knock a vaccine out of the running.

“You definitely want to bet on more than one horse,” he says.

The latest in birthday science proposes that the vertebrate with the longest life span yet measured is the mysterious Greenland shark.

Dating based on forms of carbon found in sharks’ eye lenses suggests that a large female Somniosus microcephalus was about 392 years old (give or take 120 years) when she died, says marine biologist Julius Nielsen of University of Copenhagen. Even with that uncertainty, the shark outdoes what Nielsen considers the previous record holder: a bowhead whale estimated to have lived 211 years.
The dating comes from the first use of eye-lens dating for a fish, Nielsen says. An analysis that produced the date, involving 27 other Greenland shark specimens, suggests that females don’t reach sexual maturity until they’re about 156 years old, Nielsen and his colleagues report August 12 in Science. Remarkably little basic biology is known for the Greenland shark, though.

And figuring out the age of these sharks has “stymied all solution attempts,” says Steven Campana of the University of Iceland in Reykjavik. ”Given that the Greenland shark is one of the largest carnivores in the world and the king of the food chain [in northern waters], it is almost unbelievable that we don’t know if this shark lives to 20 years or to 1,000,” says Campana, who has long studied shark aging but was not part of this research. Both extremes have been suggested.

Unlike familiar bony fish, such as salmon and cod, sharks don’t have ear bones that build up calcified rings that reveal age. Some sharks, such as the great whites, have some calcified vertebrae that serve, but the Greenland species is “a soft shark,” Nielsen says. And it’s an odd-looking one. He finds that some people are disappointed with their first sight of the big, dark, ponderous beasts because they’re a long way from the stereotype of the great white sharks’ streamlined killer look. “Definitely plump,” Nielsen says.

Working with 28 Greenland sharks of different sizes that were accidentally caught during fisheries surveys, Nielsen and his colleagues examined eye lenses. The highly specialized clear proteins in lenses start with a nugget formed in utero, and studies in mammals have scrutinized that small bit for clues to a creature’s birth date.

Nielsen’s team looked for anomalies in carbon created by the pulse of radioactivity from the 1950s bomb testing in the Pacific Ocean. Radiocarbons worked their way into, and lingered in, all the food webs on the planet. The pulse first reached the sharks’ realms in the North Atlantic in the 1960s, the scientific literature indicates. Nielsen was startled to discover that only three specimens in his collection had the carbon anomalies — and they were the smaller sharks.
He and colleagues used the size of a shark that appeared to have been born just as the bomb pulse was arriving in the ocean food system as a kind of calibration marker. Then, in an elaborate statistical analysis, they used size and growth rates to work out ages for the rest.

Campana is skeptical that Greenland sharks can live nearly 400 years. Other sharks typically live for 10 to 80 years, he says. “I certainly accept that it grows for more than a century.” But to crown the Greenland shark a record holder, he is waiting for future research.

Extreme life spans evolve just like polar bear white fur or long giraffe necks to fit into the sum of ways an organism feeds, dodges its predators and reproduces in its environment. Says James R. Carey of the University of California, Davis, who studies demography across the tree of life, “the really deeper question is once you identify a species that’s long-lived — why?”

A debate over when the gap between North and South America closed has opened a rift in the scientific community.

Analyzing existing data from ancient rocks, fossils and genetic studies, a group of researchers has assembled a defense of the conventional view that the Isthmus of Panama formed around 3 million years ago. That work rebuts papers published last year that concluded that the continental connection started millions of years earlier (SN: 5/2/15, p. 10). The authors of the new paper, published August 17 in Science Advances, caution against the “uncritical acceptance” of the older formation date.
“Those of us who are advocating the traditional view are in danger of being seen as old fuddy-duddy conservatives,” says study coauthor Harilaos Lessios, a molecular evolutionist at the Smithsonian Tropical Research Institute in Panama City. “But sometimes the traditional view is the correct one.”
The American continents drifted apart following the breakup of the Pangaea supercontinent around 200 million years ago. Eventually, the landmasses slid back together. As they reconnected, a volcanic mound on the Caribbean tectonic plate collided with South America and rose above the ocean. This new land closed a seaway between the Pacific and Atlantic oceans, rerouted ocean currents and sparked animal migrations, leaving clues that scientists on both sides of the debate are using to determine the age of the Isthmus of Panama.

Aaron O’Dea, a paleontologist at the Smithsonian Tropical Research Institute, Lessios and colleagues revisited several of those lines of evidence to date the seaway closure. For instance, fossil records reveal that land animals began migrating more frequently between the Americas around 2.7 million years ago, possible evidence of a newly available land route, O’Dea’s team concludes. Critics, though, counter that those migrations were instead driven by climate and ecosystem changes that allowed animals to migrate.
In the oceans, the closed seaway divided populations of marine organisms such as sand dollars. Over time, these populations’ genetic makeups diverged. Based on the degree of genetic change between the groups as well as fossil evidence, O’Dea’s team estimates that the seaway closed roughly 3 million years ago.

Christine Bacon, an evolutionary biologist at the University of Gothenburg in Sweden, and colleagues analyzed similar evidence last year but came to a different conclusion. The seaway closed between 23 million and 7 million years ago, Bacon and colleagues estimated in the Proceedings of the National Academy of Sciences. That study assumed a different rate of genetic divergence and looked at more species than the work by O’Dea and colleagues, Bacon says.

Rocks also trace the isthmus’s rise from the sea. Chemical traces from ancient ocean sediments record when seawater stopped mixing between the Atlantic and Pacific. Analyzing those traces, O’Dea and colleagues estimate that the seaway became relatively shallow around 12 million to 9.2 million years ago and completely shut around 2.7 million years ago.

Other rocky evidence tells a different story, proponents of the older age claim. Volcanically-forged crystals, known as zircons, found in South America date back to around 13 million to 15 million years ago. The only possible source of those crystals was in Panama, suggesting that a river washed the crystals down a land connection between Panama and South Americaaround that time, geologist Camilo Montes of the Universidad de los Andes in Bogotá, Colombia, and colleagues concluded last year in Science.
Those South American crystals may have formed closer to home, O’Dea and colleagues argue in the new paper. Similar crystals have been found elsewhere in South America, so the crystals reported by Montes and colleagues may have originated from a source in South America, not Panama, O’Dea says.

Some of the disagreement between the two sides stems from the fact that the seaway closure wasn’t a single event, says Carlos Jaramillo, a paleontologist at the Smithsonian Tropical Research Institute who coauthored the studies by Montes and Bacon. The seaway would have closed in stages, with various segments shortened and closed off over millions of years, Jaramillo says. “You can’t just use one date for everything, it depends on what you’re looking at,”he says.

Bacon is holding her ground. “They basically rehashed a mishmash of old papers,” she says of the new work. “We need to gather new data and collaborate rather than hold on to old ideas bitterly.”

Forget garlic. In real life, a tomato can defeat a vampire. And researchers have now figured out the first step to vegetable triumph.

The vampires are slim, tangling vines that look like splats of orange or yellow-green spaghetti after a toddler’s dinnertime tantrum. Botanically, the 200 or so Cuscuta species are morning glories gone bad. In the same family as the heavenly blue garden trumpets, the dodders, as they’re sometimes called, lose their roots about a week after sprouting and never grow real leaves. Why bother when you can drain food and water from the neighbors?
A dodder seedling, basically a bare stem, finds that first neighbor by writhing and groping (in slow plant time) toward attractive plant odors. “The Cuscuta can smell its victims,” says Markus Albert of the University of Tübingen in Germany.

Depending on the dodder species, victims include asparagus, melons, sugar beets, petunias, garlic, chrysanthemums and oak trees. Even worse for civilization as we know it, some Cuscuta species vampirize coffee plants and grapevines.
Certain dodders do kill tomato plants. But not the C. reflexa from Asia that Albert studies; instead, it gets its skinny little haustoria whipped. Haustoria are the organs that make plant parasitism possible. When a dodder seedling brushes against tasty prey, a haustorium disk forms and pushes out from the dodder stem with a fast-growing point. “It really looks like a vampire tooth,” Albert says.

If the prey is, say, a soybean plant, it’s doomed. The growing dodder haustorium not only exerts force but also releases enzymes that weaken the bean’s tissue. Haustorium tip cells send out projections that grasp the bean’s inner ducts for water and nutrients, diverting so much that the bean starves.

A tomato plant poked by a haustorium, however, panics. A patch of cells on the stem elongate and burst, forming a scab that stops the intruder. The haustorium stalls and eventually dies.

A gene called CuRe1 lets the tomato recognize the dodder as a dire threat, Albert and colleagues report in the July 29 Science. They transferred the gene to a normally susceptible relative and — Ha! Bite that, vampire! Albert predicts additional biochemistry could be needed to dodder-proof other crops. But for starters, researchers now know the first step in protection: A tomato’s rare power to survive a scary vampire is the ability to get really scared itself.

Female mosquitoes carrying the Zika virus can pass the infection to the next generation, lab tests show.

Among Aedes aegypti mosquitoes, thought to be the main species spreading Zika in the Americas, at least one out of every 290 lab offspring catches the virus from its mother, Texas researchers say August 29 in the Journal of Tropical Medicine and Hygiene. Infected eggs, which can survive for months on dry surfaces, could keep the virus circulating even after dry or cold spells, when adult mosquitoes die off, warns Robert Tesh of University of Texas Medical Branch in Galveston.

Earlier research had already shown that youngsters of this species can inherit related viruses, such as those causing dengue, West Nile and yellow fever. Mom-to-egg transmission though is not a given: The same research project also reported no evidence so far of this vertical transmission in 803 offspring of another possible Zika spreader, Ae. albopictus.

It’s not known how likely mosquito moms are to infect their young outside of the lab. Doing a reliable test with wild mosquitoes outdoors is a much more difficult project, the researchers say.

Contrary to many adorable children’s stories, hibernation is so not sleeping. And most animals can’t do both at the same time.

So what’s with Madagascar’s dwarf lemurs? The fat-tailed dwarf lemur slows its metabolism into true hibernation, and stays there even when brain monitoring shows it’s also sleeping. But two lemur cousins, scientists have just learned, don’t multitask. Like other animals, they have to rev their metabolisms out of hibernation if they want a nap.
Hibernating animals, in the strictest sense, stop regulating body temperature, says Peter Klopfer, cofounder of the Duke Lemur Center in Durham, N.C. “They become totally cold-blooded, like snakes.” By this definition, bears don’t hibernate; they downregulate, dropping their body temperatures only modestly, even when winter den temperatures sink lower. And real hibernation lasts months, disqualifying short-termers such as subtropical hummingbirds. The darting fliers cease temperature regulation and go truly torpid at night. “You can pick them out of the trees,” Klopfer says.

The fat-tailed dwarf lemur, Cheirogaleus medius, was the first primate hibernator discovered, snuggling deep into the softly rotting wood of dead trees. “You’d think they’d suffocate,” he says. But their oxygen demands plunge to somewhere around 1 percent of usual. As trees warm during the day and cool at night, so do these lemurs. When both a tree and its inner lemur heat up, the lemur’s brain activity reflects mammalian REM sleep.

Klopfer expected much the same from two other dwarf lemurs from an upland forest with cold, wet winters. There, C. crossleyi and C. sibreei spend three to seven months curled up underground, below a thick cushion of fallen leaves. “If you didn’t know better, you might think they were dead because they’re cold to the touch,” Klopfer says.

Unlike the tree-hibernators, the upland lemurs take periodic breaks from hibernating to sleep, Klopfer, the Lemur Center’s Marina Blanco and colleagues report in the August Royal Society Open Science. The lemurs generated some body heat of their own about once a week, which is when their brains showed signs of sleep (REM-like and slow-wave). “My suspicion is that sleep during torpor is only possible at relatively high temperatures, above 20º Celsius,” Klopfer says. Sleep may be important enough for cold-winter lemurs to come out of the storybook “long winter’s nap.”